1. Home
  2. CURV vs TNXP Comparison

CURV vs TNXP Comparison

Compare CURV & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

HOLD

Current Price

$1.89

Market Cap

159.2M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.96

Market Cap

169.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURV
TNXP
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.2M
169.8M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
CURV
TNXP
Price
$1.89
$11.96
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$1.59
N/A
AVG Volume (30 Days)
574.6K
541.1K
Earning Date
06-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$1,000,092,000.00
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
$1.15
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$0.94
$10.03
52 Week High
$3.14
$69.65

Technical Indicators

Market Signals
Indicator
CURV
TNXP
Relative Strength Index (RSI) 57.51 47.91
Support Level $1.03 $10.03
Resistance Level $1.93 $12.78
Average True Range (ATR) 0.21 0.93
MACD 0.02 0.13
Stochastic Oscillator 74.51 69.01

Price Performance

Historical Comparison
CURV
TNXP

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: